Astrocytes influence the severity of spinal muscular atrophy

Human Molecular Genetics

Volumn 24, Issue 14, 2015, Pages 4094-4102

  Rindt, Hansjörg ^a   Feng, Zhihua ^b   Mazzasette, Chiara ^b   Glascock, Jacqueline J ^a   Valdivia, David ^c   Pyles, Noah ^c   Crawford, Thomas O ^c   Swoboda, Kathryn J ^d   Patitucci, Teresa N ^e   Ebert, Allison D ^e   Sumner, Charlotte J ^c   Ko, Chien Ping ^b   Lorson, Christian L ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; SURVIVAL MOTOR NEURON PROTEIN; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; SMN1 PROTEIN, MOUSE; SURVIVAL MOTOR NEURON PROTEIN 1;

ALPHA NERVE FIBER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL DENSITY; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROPRIOCEPTION; PROTEIN EXPRESSION; SPINAL MUSCULAR ATROPHY; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DEPENDOPARVOVIRUS; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; INDUCED PLURIPOTENT STEM CELL; KNOCKOUT MOUSE; METABOLISM; NEUROMUSCULAR JUNCTION; PATHOLOGY; PHENOTYPE; SPINAL CORD;

MUS;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NEUROMUSCULAR JUNCTION; PHENOTYPE; SPINAL CORD; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 84936741397     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv148     Document Type: Article

References (40)

1. Sugarman, E.A., Nagan, N., Zhu, H., Akmaev, V.R., Zhou, Z., Rohlfs, E.M., Flynn, K., Hendrickson, B.C., Scholl, T., Sirko-Osadsa, D.A. et al. (2012) Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72, 400 specimens. Eur. J. Hum. Genet., 20, 27-32.
2. Burghes, A.H. and Beattie, C.E. (2009) Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci., 10, 597-609.
3. Park, G.H., Maeno-Hikichi, Y., Awano, T., Landmesser, L.T. and Monani, U.R. (2010) Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J. Neurosci., 30, 12005-12019.
4. Gogliotti, R.G., Quinlan, K.A., Barlow, C.B., Heier, C.R., Heckman, C.J. and Didonato, C.J. (2012) Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensorymotor defects are a consequence, not a cause, of motor neuron dysfunction. J. Neurosci., 32, 3818-3829.
5. Paez-Colasante, X., Seaberg, B., Martinez, T.L., Kong, L., Sumner, C.J. and Rimer, M. (2013) Improvement of neuromuscular synaptic phenotypes without enhanced survival and motor function in severe spinal muscular atrophy mice selectively rescued in motor neurons. PLoS ONE, 8, e75866.
6. Lutz, C.M., Kariya, S., Patruni, S., Osborne, M.A., Liu, D., Henderson, C.E., Li, D.K., Pellizzoni, L., Rojas, J., Valenzuela, D.M. et al. (2011) Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy. J. Clin. Invest., 121, 3029-3041.
7. Martinez, T.L., Kong, L., Wang, X., Osborne, M.A., Crowder, M. E., Van Meerbeke, J.P., Xu, X., Davis, C., Wooley, J., Goldhamer, D.J. et al. (2012) Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J. Neurosci., 32, 8703-8715.
8. Lee, A.J., Awano, T., Park, G.H. and Monani, U.R. (2012) Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy. PLoS ONE, 7, e46353.
9. Gavrilina, T.O., McGovern, V.L., Workman, E., Crawford, T.O., Gogliotti, R.G., DiDonato, C.J., Monani, U.R., Morris, G.E. and Burghes, A.H. (2008) NeuronalSMNexpression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum. Mol. Genet., 17, 1063-1075.
10. Hamilton, G. and Gillingwater, T.H. (2013) Spinal muscular atrophy: going beyond the motor neuron. Trends Mol. Med., 19, 40-50.
11. Lee, Y., Messing, A., Su, M. and Brenner, M. (2008) GFAP promoter elements required for region-specific and astrocytespecific expression. Glia, 56, 481-493.
12. 2+ signaling pathway in vivo by adeno-associated viral transduction. Neuroscience, 170, 992-1003.
13. Foust, K.D., Nurre, E., Montgomery, C.L., Hernandez, A., Chan, C.M. and Kaspar, B.K. (2009) IntravascularAAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol., 27, 59-65.
14. Le, T.T., Pham, L.T., Butchbach, M.E., Zhang, H.L., Monani, U. R., Coovert, D.D., Gavrilina, T.O., Xing, L., Bassell, G.J. and Burghes, A.H. (2005) SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet., 14, 845-857.
15. Allen, N.J. and Barres, B.A. (2009) Neuroscience: Glia-more than just brain glue. Nature, 457, 675-677.
16. Butchbach, M.E., Edwards, J.D. and Burghes, A.H. (2007) Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy. Neurobiol. Dis., 27, 207-219.
17. Bowerman, M., Murray, L.M., Beauvais, A., Pinheiro, B. and Kothary, R. (2012) A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul. Disord., 22, 263-276.
18. Ling, K.K., Gibbs, R.M., Feng, Z. and Ko, C.P. (2012) Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum. Mol. Genet., 21, 185-195.
19. Passini, M.A. and Cheng, S.H. (2011) Prospects for the gene therapy of spinal muscular atrophy. Trends Mol. Med., 17, 259-265.
20. Ling, K.K., Lin, M.Y., Zingg, B., Feng, Z. and Ko, C.P. (2010) Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinalmuscular atrophy. PLoS ONE, 5, e15457.
21. Mentis, G.Z., Blivis, D., Liu, W., Drobac, E., Crowder, M.E., Kong, L., Alvarez, F.J., Sumner, C.J. and O'Donovan, M.J. (2011) Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron, 69, 453-467.
22. Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C. and Gage, F. H. (2012) Mechanisms underlying inflammation in neurodegeneration. Cell, 140, 918-934.
23. Brock, T.O. and McIlwain, D.L. (1984) Astrocytic proteins in the dorsal and ventral roots in amyotrophic lateral sclerosis and Werdnig-Hoffmann disease. J. Neuropathol. Exp. Neurol., 43, 609-619.
24. Kuru, S., Sakai, M., Konagaya, M., Yoshida, M., Hashizume, Y. and Saito, K. (2009) An autopsy case of spinal muscular atrophy type III (Kugelberg-Welander disease). Neuropathology, 29, 63-67.
25. Dachs, E., Hereu, M., Piedrafita, L., Casanovas, A., Caldero, J. and Esquerda, J.E. (2011) Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J. Neuropathol. Exp. Neurol., 70, 444-461.
26. McGivern, J.V., Patitucci, T.N., Nord, J.A., Barabas, M.E., Stucky, C.L. and Ebert, A.D. (2013) Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia, 61, 1418-1428.
27. Schrank, B., Gotz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith, A.G. and Sendtner, M. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA, 94, 9920-9925.
28. Dominguez, E., Marais, T., Chatauret, N., Benkhelifa-Ziyyat, S., Duque, S., Ravassard, P., Carcenac, R., Astord, S., Pereira de Moura, A., Voit, T. et al. (2011) Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum. Mol. Genet., 20, 681-693.
29. Foust, K.D., Wang, X., McGovern, V.L., Braun, L., Bevan, A.K., Haidet, A.M., Le, T.T., Morales, P.R., Rich, M.M., Burghes, A. H. et al. (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol., 28, 271-274.
30. Glascock, J.J., Shababi, M., Wetz, M.J., Krogman, M.M. and Lorson, C.L. (2012) Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy. Biochem. Biophys. Res. Commun., 417, 376-381.
31. Passini, M.A., Bu, J., Roskelley, E.M., Richards, A.M., Sardi, S.P., O'Riordan, C.R., Klinger, K.W., Shihabuddin, L.S. and Cheng, S.H. (2010) CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J. Clin. Invest., 120, 1253-1264.
32. Valori, C.F., Ning, K., Wyles, M., Mead, R.J., Grierson, A.J., Shaw, P.J. and Azzouz, M. (2010) Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci. Transl. Med., 2, 35ra42.
33. Williams, E.C., Zhong, X., Mohamed, A., Li, R., Liu, Y., Dong, Q., Ananiev, G.E., Mok, J.C., Lin, B.R., Lu, J. et al. (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum. Mol. Genet., 23, 2968-2980.
34. Lioy, D.T., Garg, S.K., Monaghan, C.E., Raber, J., Foust, K.D., Kaspar, B.K., Hirrlinger, P.G., Kirchhoff, F., Bissonnette, J.M., Ballas, N. et al. (2011) A role for glia in the progression of Rett's syndrome. Nature, 475, 497-500.
35. Oliveira, A.L., Hydling, F., Olsson, E., Shi, T., Edwards, R.H., Fujiyama, F., Kaneko, T., Hokfelt, T., Cullheim, S. and Meister, B. (2003) Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia. Synapse, 50, 117-129.
36. Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C.F. and Krainer, A.R. (2011) Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature, 478, 123-126.
37. Tarabal, O., Caraballo-Miralles, V., Cardona-Rossinyol, A., Correa, F.J., Olmos, G., Llado, J., Esquerda, J.E. and Caldero, J. (2014) Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy. J. Neuropathol. Exp. Neurol., 73, 519-535.
38. Glascock, J.J., Osman, E.Y., Coady, T.H., Rose, F.F., Shababi, M. and Lorson, C.L. (2011) Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice. J. Visualized Exp.: JoVE, 56, 2968.
39. Grieger, J.C., Choi, V.W. and Samulski, R.J. (2006) Production and characterization of adeno-associated viral vectors. Nat. Protoc., 1, 1412-1428.
40. Ebert, A.D., Shelley, B.C., Hurley, A.M., Onorati, M., Castiglioni, V., Patitucci, T.N., Svendsen, S.P., Mattis, V.B., McGivern, J.V., Schwab, A.J. et al. (2013) EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs. Stem Cell Res., 10, 417-427.